Did you know ? If you order before Friday 14h we deliver 90PCT of the the time next Tuesday, Gentaur another in time delivery

Pubmed ID :30266802
Publication Date : //

Dual Targeting of Aurora Kinases with AMG 900 Exhibits Potent Preclinical Activity Against Acute Myeloid Leukemia with Distinct Post-Mitotic Outcomes.


Aurora kinase A and B have essential and non-overlapping roles in mitosis, with elevated expression in a subset of human cancers, including acute myeloid leukemia (AML). In this study, pan-aurora kinase inhibitor (AKI) AMG 900 distinguishes itself as an anti-leukemic agent that is more uniformly potent against a panel of AML cell lines than are isoform-selective AKIs and classic AML drugs. AMG 900 inhibited AML cell growth by inducing polyploidization and/or apoptosis. AMG 900 and aurora-B-selective inhibitor AZD1152-hQPA showed comparable cellular effects on AML lines that do not harbor a -ITD mutation. AMG 900 was active against P-glycoprotein-expressing AML cells resistant to AZD1152-hQPA and was effective at inducing expression of megakaryocyte-lineage markers (CD41, CD42) on human CHRF-288-11 cells and mouse cells. In MOLM-13 cells, inhibition of p-histone H3 by AMG 900 was associated with polyploidy, extra centrosomes, accumulation of p53 protein, apoptosis, and cleavage of Bcl-2 protein. Co-administration of cytarabine (Ara-C) with AMG 900 potentiated cell killing in a subset of AML lines, with evidence of attenuated polyploidization. AMG 900 inhibited the proliferation of primary human bone marrow cells in culture, with a better proliferation recovery profile relative to classic antimitotic drug docetaxel. , AMG 900 significantly reduced tumor burden in a systemic MOLM-13 xenograft model where we demonstrate the utility of 3'-deoxy-3'-F-fluorothymidine [F]FLT positron emission tomographic (PET)-CT imaging to measure the antiproliferative effects of AMG 900 in skeletal tissues in mice.

Authors : Payton Marc , Cheung Hung-Kam , Ninniri Maria Stefania S , Marinaccio Christian , Wayne William C , Hanestad Kelly , Crispino John D , Juan Gloria , Coxon Angela ,

Related products :

Catalog number Product name Quantity
27-366 ELL encodes an RNA polymerase II transcription factor that undergoes frequent translocation in acute myeloid leukemia (AML). In addition to its elongation activity, ELL contains a novel type of RNA po 0.05 mg
orb60267 JNJ-7706621 A Dual Inhibitor of Cyclin-Dependent Kinases and Aurora Kinases. In vitro kinase IC50 CDK1_Cyclin B(0.009 umol_L), Aurora-A(0.011 umol_L). For research use only. 1 mg
T18-013-N1 Matched Tumor_ Normal Human Leukemia, bone marrow Tissue Lysates (Acute Myeloid Leukemia) 0.1 mg
T18-015-T2 Matched Tumor_ Normal Human Leukemia, bone marrow Tissue Lysates (Acute Myeloid Leukemia) 0.1 mg
T18-016-N1 Matched Tumor_ Normal Human Leukemia, bone marrow Tissue Lysates (Acute Myeloid Leukemia) 0.1 mg
T18-016-N2 Matched Tumor_ Normal Human Leukemia, bone marrow Tissue Lysates (Acute Myeloid Leukemia) 0.1 mg
T18-016-T1 Matched Tumor_ Normal Human Leukemia, bone marrow Tissue Lysates (Acute Myeloid Leukemia) 0.1 mg
T18-020-T2 Matched Tumor_ Normal Human Leukemia, bone marrow Tissue Lysates (Acute Myeloid Leukemia) 0.1 mg
T18-020-T1 Matched Tumor_ Normal Human Leukemia, bone marrow Tissue Lysates (Acute Myeloid Leukemia) 0.1 mg
T18-020-N2 Matched Tumor_ Normal Human Leukemia, bone marrow Tissue Lysates (Acute Myeloid Leukemia) 0.1 mg
T18-020-N1 Matched Tumor_ Normal Human Leukemia, bone marrow Tissue Lysates (Acute Myeloid Leukemia) 0.1 mg
T18-019-T2 Matched Tumor_ Normal Human Leukemia, bone marrow Tissue Lysates (Acute Myeloid Leukemia) 0.1 mg
T18-014-T2 Matched Tumor_ Normal Human Leukemia, bone marrow Tissue Lysates (Acute Myeloid Leukemia) 0.1 mg
T18-012-T1 Matched Tumor_ Normal Human Leukemia, bone marrow Tissue Lysates (Acute Myeloid Leukemia) 0.1 mg
T18-015-T1 Matched Tumor_ Normal Human Leukemia, bone marrow Tissue Lysates (Acute Myeloid Leukemia) 0.1 mg
T18-013-T1 Matched Tumor_ Normal Human Leukemia, bone marrow Tissue Lysates (Acute Myeloid Leukemia) 0.1 mg
T18-012-T2 Matched Tumor_ Normal Human Leukemia, bone marrow Tissue Lysates (Acute Myeloid Leukemia) 0.1 mg
T18-013-T2 Matched Tumor_ Normal Human Leukemia, bone marrow Tissue Lysates (Acute Myeloid Leukemia) 0.1 mg
T18-014-N1 Matched Tumor_ Normal Human Leukemia, bone marrow Tissue Lysates (Acute Myeloid Leukemia) 0.1 mg
T18-014-N2 Matched Tumor_ Normal Human Leukemia, bone marrow Tissue Lysates (Acute Myeloid Leukemia) 0.1 mg
T18-014-T1 Matched Tumor_ Normal Human Leukemia, bone marrow Tissue Lysates (Acute Myeloid Leukemia) 0.1 mg
T18-015-N2 Matched Tumor_ Normal Human Leukemia, bone marrow Tissue Lysates (Acute Myeloid Leukemia) 0.1 mg
T18-012-N1 Matched Tumor_ Normal Human Leukemia, bone marrow Tissue Lysates (Acute Myeloid Leukemia) 0.1 mg
T18-013-N2 Matched Tumor_ Normal Human Leukemia, bone marrow Tissue Lysates (Acute Myeloid Leukemia) 0.1 mg
T18-019-T1 Matched Tumor_ Normal Human Leukemia, bone marrow Tissue Lysates (Acute Myeloid Leukemia) 0.1 mg


https://antibody-antibodies.com/ | https://gentaur.com/ | https://gen-script.com/ | https://diagenox.com/ | https://clonagen.com/ | http://gentaursearch.com/ | http://gentaurpub.com/ | https://gentaur-online.com/ | http://anti-anti-pdf.com/ | http://gentaur-worldwide.com/

 

Gentaur Belgium BVBA BE0473327336
Voortstraat 49, 1910 Kampenhout BELGIUM
Tel 0032 16 58 90 45

Fax 0032 16 50 90 45
[email protected] | Gentaur | Gentaur





Gentaur Ltd.
Unicorn House, Station Cl
Hertfordshire, Potters Bar EN6 1TL
Whetstone London N20 9BH
Tel 020 3393 8531 Fax 020 8445 9411
[email protected] | Gentaur | Gentaur

 

 




Gentaur France SARL
9, rue Lagrange, 75005 Paris
Tel 01 43 25 01 50

Fax 01 43 25 01 60
RCS Paris B 484 237 888

SIRET 48423788800017
RIB 30004 00187 00010092253 10
BNP PARIBAS PARIS PL MAUBERT BIC BNPAFRPPPRG
IBAN FR76 3000 4001 8700 0100 9225 310
[email protected] | Gentaur | Gentaur

Gentaur GmbH
Marienbongard 20
52062 Aachen Deutschland
Support Karolina Elandt
Tel: +49 0241 40 08 90 86, +49 0241 95 78 94 78, +49 0241 40 08 90 86
Fax: (+49) 241 56 00 47 88

Logistic :0241 40 08 90 86
Bankleitzahl 39050000
IBAN lautet DE8839050000107569353
Handelsregister Aachen HR B 16058
Umsatzsteuer-Identifikationsnummer *** DE 815175831
Steuernummer 201/5961/3925
[email protected] | Gentaur | Gentaur

Gentaur U.S.A
Genprice Inc, Logistics
547, Yurok Circle
San Jose, CA 95123
CA 95123
Tel (408) 780-0908,
Fax (408) 780-0908,
[email protected]

Genprice Inc, Invoices and accounting
6017 Snell Ave, Ste 357
San Jose, CA 95123




Gentaur Nederland BV
NL850396268B01 KVK nummer 52327027
Kuiper 1
5521 DG Eersel Nederland
Tel:  0208-080893  Fax: 0497-517897
[email protected] | Gentaur | Gentaur
IBAN: NL04 RABO 0156 9854 62   SWIFT RABONL2U






Gentaur Spain
tel:0911876558
[email protected] | Gentaur | Gentaur






ГЕНТАУЪР БЪЛГАРИЯ
ID # 201 358 931 /BULSTAT
София 1000, ул. "Граф Игнатиев" 53 вх. В, ет. 2
Tel 0035924682280 Fax 0035924808322
e-mail: [email protected] | Gentaur | Gentaur
IBAN: BG11FINV91501014771636
BIC: FINVBGSF

Gentaur Poland Sp. z o.o.


ul. Grunwaldzka 88/A m.2
81-771 Sopot, Poland
TEL Gdansk 058 710 33 44 FAX  058 710 33 48              

[email protected] | Gentaur | Gentaur

Other countries

Österreich +43720880899

Canada Montreal +15149077481

Ceská republika Praha +420246019719

Danmark +4569918806

Finland Helsset +358942419041

Magyarország Budapest +3619980547

Ireland Dublin+35316526556

Luxembourg+35220880274

Norge Oslo+4721031366

Sverige Stockholm+46852503438

Schweiz Züri+41435006251

US New York+17185132983

Gentaur Italy
SRL IVA IT03841300167
Piazza Giacomo Matteotti, 6
24122 Bergamo Tel 02 36 00 65 93
Fax 02 36 00 65 94
[email protected] | Gentaur | Gentaur